Use of GoFundMe® to crowdfund complementary and alternative medicine treatments for cancer.

PurposeComplementary and alternative medicine (CAM) use is common amongst cancer patients. However, there is growing concern about its safety and efficacy. Online crowdfunding campaigns represent a unique avenue to understand the cancer patient's perspective for using CAM or declining conventional cancer therapy (CCT).MethodsFive hundred GoFundMe campaigns from 2012 to 2019 detailing financial need for cancer treatment were randomly selected and reviewed for endorsement of CAM use, reasons for using CAM, and reasons for declining CCT. Descriptive statistics were used to compare patient and campaign characteristics between 250 CAM users and 250 non-CAM users.ResultsCompared to non-CAM users, CAM users were more likely to be female (70% vs. 54%, p < 0.01), to report more stage IV cancer (54% vs. 12%, p < 0.01), and to have a history of delayed, missed, or misdiagnosis (10% vs. 4%, p < 0.01). Reasons for using CAM include endorsing curative/therapeutic effects 212 (85%), pain/stress reduction 137 (55%), and dissatisfaction with current or past medical treatment options 105 (42%). 87 (35%) CAM users that declined CCT reported that they wanted to try to fight off cancer using CAM first 57 (61%), that CCT was too "toxic" to the body 39 (42%), and cancer was already too advanced, so that CCT would be futile or too aggressive 25 (27%).ConclusionCancer patients on GoFundMe using CAM highly value quality of life, comfort, and autonomy. Physicians should educate themselves on CAM to set realistic expectations and provide comprehensive counseling of the risks and benefits of CAM usage to patients who choose to use CAM to either augment or completely replace CCT

Percutaneous Achilles Tendon Repair Using Ultrasound Guidance: An Intraoperative Ultrasound Technique

Rupture of the Achilles tendon is a common injury seen in patients of varying ages and activity levels. There are many considerations for treatment of these injuries, with both operative and nonoperative management providing satisfactory outcomes in the literature. The decision to proceed with surgical intervention should be individualized for each patient, including the patient\u27s age, future athletic goals, and comorbidities. Recently, a minimally invasive percutaneous approach to repair the Achilles tendon has been proposed as an equivalent alternative to the traditional open repair, while avoiding wound complications associated with larger incisions. However, many surgeons have been hesitant to adopt these approaches due to poor visualization, concern that suture capture in the tendon is not as robust, and the potential for iatrogenic sural nerve injury. The purpose of this Technical Note is to describe a technique using high-resolution ultrasound guidance intraoperatively during minimally invasive repair of the Achilles tendon. This technique minimizes the drawbacks of poor visualization associated with percutaneous repair, while providing the benefit of a minimally invasive approach

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Objective To investigate whether angiotensin receptor blockers protect against Alzheimer’s disease and dementia or reduce the progression of both diseases

Blood Flow Restriction Training After Patellar INStability (BRAINS Trial)

Background Patellar instability is a common and understudied condition that disproportionally affects athletes and military personnel. The rate of post-traumatic osteoarthritis that develops following a patellar dislocation can be up to 50% of individuals 5–15 years after injury. Conservative treatment is the standard of care for patellar instability however, there are no evidence-informed rehabilitation guidelines in the scientific literature. The purpose of this study is to assess the effectiveness of blood-flow restriction training (BFRT) for patellar instability. Our hypotheses are that this strategy will improve patient-reported outcomes and accelerate restoration of symmetric strength and knee biomechanics necessary to safely return to activity. Methods/Design This is a parallel-group, superiority, randomized, double-blinded, placebo-controlled clinical trial at the University of Kentucky, sports medicine clinic that aims to recruit 78 patients with acute patellar dislocations randomly allocated into two groups: (1) sham BFRT and (2) BFRT. Both groups will receive the current standard of care physical therapy 3 times per week for up to 9 weeks. Physical therapy sessions will consist of typical standard of care treatment followed by BFRT or sham BFRT. Primary outcomes include the Norwich Patellar Instability Scale, quadriceps strength, and imaging and biochemical biomarkers of cartilage degradation. Discussion The current standard of care for non-operative treatment of patellar instability is highly variable does not adequately address the mechanisms necessary to restore lower extremity function and protect the long-term health of articular cartilage following injury. This proposed novel intervention strategy uses an easily implementable therapy to evaluate if BFRT significantly improves patient-reported outcomes, function, and joint health over the first year of recovery. Trial Registration Blood Flow Restriction Training, Aspiration, and Intraarticular Normal Saline (BRAINS) NCT04554212. Registered on 18 September 2020

A world of cobenefits : solving the global nitrogen challenge

Houlton, Benjamin Z. University of California. John Muir Institute of the Environment. Davis, CA, USA.Houlton, Benjamin Z. University of California. Department of Land, Air and Water Resources. Davis, CA, USA.Almaraz, Maya. University of California. Department of Land, Air and Water Resources. Davis, CA, USA.Aneja, Viney. North Carolina State University at Raleigh. Department of Marine, Earth, and Atmospheric Sciences. Raleigh, NC, USA.Austin, Amy T. Universidad de Buenos Aires. Facultad de Agronomía. Instituto de Investigaciones Fisiológicas y Ecológicas Vinculadas a la Agricultura (IFEVA). Buenos Aires, Argentina.Austin, Amy T. CONICET – Universidad de Buenos Aires. Instituto de Investigaciones Fisiológicas y Ecológicas Vinculadas a la Agricultura (IFEVA). Buenos Aires, Argentina.Bai, Edith. Chinese Academy of Sciences. Institute of Applied Ecology. CAS Key Laboratory of Forest Ecology and Management. Shenyang, China.Bai, Edith. Northeast Normal University. School of Geographical Sciences. Changchun, China.Cassman, Kenneth. University of Nebraska – Lincoln. Department of Agronomy and Horticulture. Lincoln. NE, USA.Compton, Jana E. Environmental Protection Agency. Western Ecology Division. Washington, DC, USA.Davidson, Eric A. University of Maryland Center for Environmental Science. Appalachian Laboratory. Cambridge, MD, USA.865-872Nitrogen is a critical component of the economy, food security, and planetary health. Many of the world's sustainability targets hinge on global nitrogen solutions, which, in turn, contribute lasting benefits for (i) world hunger; (ii) soil, air, and water quality; (iii) climate change mitigation; and (iv) biodiversity conservation. Balancing the projected rise in agricultural nitrogen demands while achieving these 21st century ideals will require policies to coordinate solutions among technologies, consumer choice, and socioeconomic transformation

Ergocalciferol in New-onset Type 1 diabetes: A Randomized Controlled Trial

Background: The impact of the anti-inflammatory and immunomodulatory actions of Vitamin D on the duration of partial clinical remission (PR) in youth with type 1 diabetes (T1D) is unclear. Objective: To determine the effect of adjunctive ergocalciferol on residual β-cell function (RBCF) and PR in youth with newly-diagnosed T1D who were maintained on a standardized insulin treatment protocol. Hypothesis: Ergocalciferol supplementation increases RBCF and prolongs PR. Methods: A 12-month randomized, double-blind, placebo-controlled trial of 50,000 IU of ergocalciferol per week for 2 months, and then once every 2 weeks for 10 months, versus placebo in 36 subjects of ages 10-21years(y), with T1D ofmonths, and a stimulated C-peptide (SCP) level of ≥0.2nmol/L (≥0.6ng/mL). The ergocalciferol group had 18 randomized subjects (10m/ 8f), mean age 13.3±2.8y; while the control group had 18 subjects (14m/4f), age 14.3±2.9y. Results: The ergocalciferol treatment group had significantly higher serum 25-hydroxyvitamin D at 6 months (p=0.01) and 9 months (p=0.02) than the placebo group. At 12 months, the ergocalciferol group had a significantly lower serum TNF-α concentration (p=0.03). There were no significant differences between the groups at each timepoint from baseline to 12 months for SCP concentration (p=0.08), HbA1c (p=0.09), insulin-dose-adjusted A1c (IDAA1c), or total daily dose of insulin. Temporal trends for rising HbA1c (p=0.044) and IDAA1c (p=0.015) were significantly blunted in the ergocalciferol group. Conclusions: Ergocalciferol significantly reduced serum TNF-α concentration and the rates of increase in both A1c and IDAA1c suggesting a protection of RBCF and PR in youth with newly-diagnosed T1D

DynaSim: a MATLAB toolbox for neural modeling and simulation

[EN] DynaSim is an open-source MATLAB/GNU Octave toolbox for rapid prototyping of neural models and batch simulation management. It is designed to speed up and simplify the process of generating, sharing, and exploring network models of neurons with one or more compartments. Models can be specified by equations directly (similar to XPP or the Brian simulator) or by lists of predefined or custom model components. The higher-level specification supports arbitrarily complex population models and networks of interconnected populations. DynaSim also includes a large set of features that simplify exploring model dynamics over parameter spaces, running simulations in parallel using both multicore processors and high-performance computer clusters, and analyzing and plotting large numbers of simulated data sets in parallel. It also includes a graphical user interface (DynaSim GUI) that supports full functionality without requiring user programming. The software has been implemented in MATLAB to enable advanced neural modeling using MATLAB, given its popularity and a growing interest in modeling neural systems. The design of DynaSim incorporates a novel schema for model specification to facilitate future interoperability with other specifications (e.g., NeuroML, SBML), simulators (e.g., NEURON, Brian, NEST), and web-based applications (e.g., Geppetto) outside MATLAB. DynaSim is freely available at http://dynasimtoolbox.org. This tool promises to reduce barriers for investigating dynamics in large neural models, facilitate collaborative modeling, and complement other tools being developed in the neuroinformatics community.This material is based upon research supported by the U.S. Army Research Office under award number ARO W911NF-12-R-0012-02, the U.S. Office of Naval Research under award number ONR MURI N00014-16-1-2832, and the National Science Foundation under award number NSF DMS-1042134 (Cognitive Rhythms Collaborative: A Discovery Network)Sherfey, JS.; Soplata, AE.; Ardid-Ramírez, JS.; Roberts, EA.; Stanley, DA.; Pittman-Polletta, BR.; Kopell, NJ. (2018). DynaSim: a MATLAB toolbox for neural modeling and simulation. Frontiers in Neuroinformatics. 12:1-15. https://doi.org/10.3389/fninf.2018.00010S11512Bokil, H., Andrews, P., Kulkarni, J. E., Mehta, S., & Mitra, P. P. (2010). Chronux: A platform for analyzing neural signals. Journal of Neuroscience Methods, 192(1), 146-151. doi:10.1016/j.jneumeth.2010.06.020Brette, R., Rudolph, M., Carnevale, T., Hines, M., Beeman, D., Bower, J. M., … Destexhe, A. (2007). Simulation of networks of spiking neurons: A review of tools and strategies. Journal of Computational Neuroscience, 23(3), 349-398. doi:10.1007/s10827-007-0038-6Börgers, C., & Kopell, N. (2005). Effects of Noisy Drive on Rhythms in Networks of Excitatory and Inhibitory Neurons. Neural Computation, 17(3), 557-608. doi:10.1162/0899766053019908Ching, S., Cimenser, A., Purdon, P. L., Brown, E. N., & Kopell, N. J. (2010). Thalamocortical model for a propofol-induced  -rhythm associated with loss of consciousness. Proceedings of the National Academy of Sciences, 107(52), 22665-22670. doi:10.1073/pnas.1017069108Delorme, A., & Makeig, S. (2004). EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. Journal of Neuroscience Methods, 134(1), 9-21. doi:10.1016/j.jneumeth.2003.10.009Durstewitz, D., Seamans, J. K., & Sejnowski, T. J. (2000). Neurocomputational models of working memory. Nature Neuroscience, 3(S11), 1184-1191. doi:10.1038/81460EatonJ. W. BatemanD. HaubergS. WehbringR. GNU Octave Version 4.2.0 Manual: A High-Level Interactive Language for Numerical Computations2016Ermentrout, B. (2002). Simulating, Analyzing, and Animating Dynamical Systems. doi:10.1137/1.9780898718195FitzHugh, R. (1955). Mathematical models of threshold phenomena in the nerve membrane. The Bulletin of Mathematical Biophysics, 17(4), 257-278. doi:10.1007/bf02477753Gewaltig, M.-O., & Diesmann, M. (2007). NEST (NEural Simulation Tool). Scholarpedia, 2(4), 1430. doi:10.4249/scholarpedia.1430Gleeson, P., Crook, S., Cannon, R. C., Hines, M. L., Billings, G. O., Farinella, M., … Silver, R. A. (2010). NeuroML: A Language for Describing Data Driven Models of Neurons and Networks with a High Degree of Biological Detail. PLoS Computational Biology, 6(6), e1000815. doi:10.1371/journal.pcbi.1000815Goodman, D. (2008). Brian: a simulator for spiking neural networks in Python. Frontiers in Neuroinformatics, 2. doi:10.3389/neuro.11.005.2008Goodman, D. F. M. (2009). The Brian simulator. Frontiers in Neuroscience, 3(2), 192-197. doi:10.3389/neuro.01.026.2009Hines, M. L., & Carnevale, N. T. (1997). The NEURON Simulation Environment. Neural Computation, 9(6), 1179-1209. doi:10.1162/neco.1997.9.6.1179Hodgkin, A. L., & Huxley, A. F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. The Journal of Physiology, 117(4), 500-544. doi:10.1113/jphysiol.1952.sp004764Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., … Wang. (2003). The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics, 19(4), 524-531. doi:10.1093/bioinformatics/btg015Izhikevich, E. M. (2003). Simple model of spiking neurons. IEEE Transactions on Neural Networks, 14(6), 1569-1572. doi:10.1109/tnn.2003.820440Kopell, N., Ermentrout, G. B., Whittington, M. A., & Traub, R. D. (2000). Gamma rhythms and beta rhythms have different synchronization properties. Proceedings of the National Academy of Sciences, 97(4), 1867-1872. doi:10.1073/pnas.97.4.1867Kramer, M. A., Roopun, A. K., Carracedo, L. M., Traub, R. D., Whittington, M. A., & Kopell, N. J. (2008). Rhythm Generation through Period Concatenation in Rat Somatosensory Cortex. PLoS Computational Biology, 4(9), e1000169. doi:10.1371/journal.pcbi.1000169Lorenz, E. N. (1963). Deterministic Nonperiodic Flow. Journal of the Atmospheric Sciences, 20(2), 130-141. doi:10.1175/1520-0469(1963)0202.0.co;2Markram, H., Meier, K., Lippert, T., Grillner, S., Frackowiak, R., Dehaene, S., … Saria, A. (2011). Introducing the Human Brain Project. Procedia Computer Science, 7, 39-42. doi:10.1016/j.procs.2011.12.015McDougal, R. A., Morse, T. M., Carnevale, T., Marenco, L., Wang, R., Migliore, M., … Hines, M. L. (2016). Twenty years of ModelDB and beyond: building essential modeling tools for the future of neuroscience. Journal of Computational Neuroscience, 42(1), 1-10. doi:10.1007/s10827-016-0623-7Meng, L., Kramer, M. A., Middleton, S. J., Whittington, M. A., & Eden, U. T. (2014). A Unified Approach to Linking Experimental, Statistical and Computational Analysis of Spike Train Data. PLoS ONE, 9(1), e85269. doi:10.1371/journal.pone.0085269Morris, C., & Lecar, H. (1981). Voltage oscillations in the barnacle giant muscle fiber. Biophysical Journal, 35(1), 193-213. doi:10.1016/s0006-3495(81)84782-0Rudolph, M., & Destexhe, A. (2007). How much can we trust neural simulation strategies? Neurocomputing, 70(10-12), 1966-1969. doi:10.1016/j.neucom.2006.10.138Stimberg, M., Goodman, D. F. M., Benichoux, V., & Brette, R. (2014). Equation-oriented specification of neural models for simulations. Frontiers in Neuroinformatics, 8. doi:10.3389/fninf.2014.00006Traub, R. D., Buhl, E. H., Gloveli, T., & Whittington, M. A. (2003). Fast Rhythmic Bursting Can Be Induced in Layer 2/3 Cortical Neurons by Enhancing Persistent Na+Conductance or by Blocking BK Channels. Journal of Neurophysiology, 89(2), 909-921. doi:10.1152/jn.00573.200

Higher copy numbers of the potato RB transgene correspond to enhanced transcript and late blight resistance levels.

Late blight of potato ranks among the costliest of crop diseases worldwide. Host resistance offers the best means for controlling late blight, but previously deployed single resistance genes have been short-lived in their effectiveness. The foliar blight resistance gene RB, previously cloned from the wild potato Solanum bulbocastanum, has proven effective in greenhouse tests of transgenic cultivated potato. In this study, we examined the effects of the RB transgene on foliar late blight resistance in transgenic cultivated potato under field production conditions. In a two-year replicated trial, the RB transgene, under the control of its endogenous promoter, provided effective disease resistance in various genetic backgrounds, including commercially prominent potato cultivars, without fungicides. RB copy numbers and transcript levels were estimated with transgene-specific assays. Disease resistance was enhanced as copy numbers and transcript levels increased. The RB gene, like many other disease resistance genes, is constitutively transcribed at low levels. Transgenic potato lines with an estimated 15 copies of the RB transgene maintain high RB transcript levels and were ranked among the most resistant of 57 lines tested. We conclude that even in these ultra–high copy number lines, innate RNA silencing mechanisms have not been fully activated. Our findings suggest resistance-gene transcript levels may have to surpass a threshold before triggering RNA silencing. Strategies for the deployment of RB are discussed in light of the current research